Introduction
Gliomas, which are the most aggressive type of brain tumors, show high morbidity, a high recurrence rate, and high mortality. Survival from gliomas depends on the tumor type and grades of malignancy[
1]. According to the World Health Organization (WHO) standards, gliomas are classified into four malignant grades. WHO I–II gliomas can be treated with surgery and chemoradiotherapy, and are generally associated with a survival time of 5 to 10 years. WHO III-IV gliomas have a survival time of only 9–12 months, because of the inefficacy of surgery and chemoradiotherapy. In addition, over 50% of low-grade gliomas undergo malignant transformation into high-grade gliomas within 5–10 years during recurrence[
2,
3]. Malignant transformation of a glioma is a very complex process, which is associated with poor prognosis and reduced survival times. Hence, there are ongoing efforts to increase the understanding of glioma malignant progression.
To date, oncology research has shown that the malignant transformation of a tumor is closely related to cellular metabolism, mainly through the large-scale genetic and protein analyses[
4,
5]. Nevertheless, variations in these upstream events are not sufficient to establish the molecular mechanisms of cell metabolic changes in glioma malignant progression. Metabolites, downstream of both transcription and translation, are potentially a better indicator of enzyme activity[
6]. Thus, highthroughput metabonomics analysis is very helpful to gain a better understanding of the molecular mechanisms of glioma malignant transformation and to exploit biomarkers for prognosis monitoring. In the previous work, MacKinnon
et al. performed metabolic profiling of glioma tissues and their normal counterparts[
7]. Recent studies have further highlighted metabolic profiling of glioma tissues of different grades[
8‐
10]. Despite considerable progress in understanding metabolomics profiling of glioma tissues, ischemia and hypoxia associated with tissue sample preparation might cause metabolic degradation, directly affecting the concentrations of specific metabolites between the low- and high-grade glioma[
9]. As a prerequisite to the analysis of more complicated tumor tissues, cell lines are the most relevant model systems for exploring metabolic information that correlates with their biological characteristics. Moreover, data generated by metabolic profiling of individual cells could be controllable, highly stable, and repeatable[
11,
12]. Despite these advantages, studies of cell lines are less extensive than metabolic analysis of glioma tissues.
In the present study, we conducted 1H NMR-based metabolic profiling of cell lines from glioma tissues of different malignant grades, focusing on metabolic profiles that are relevant to the malignant features. The malignancy-associated metabolites identified directly from cell lines’ spectra could be useful to further determine the molecular mechanisms underlying malignant transformation, and to provide a rational basis for developing non-invasive biomarkers for gliomas prognosis monitoring.
Discussion
Previous studies have documented the global metabolomic profiling of glioma tissues of different grades and considerable progress has been made toward understanding the underlying metabolic alterations associated with the progression of gliomas. However, researchers noted the limitation that ischemia and hypoxia cause metabolic degradation in glioma tissues, which could seriously affect the concentrations of specific metabolites. In the present work, we identified the malignancy-associated metabolomic signature directly from the glioma cell lines using
1H NMR-based metabolic profiling. According to references[
1,
2], malignant gliomas(WHO II) and glioblastoma( WHO IV) are the most typical gliomas involved in malignant transformation. Thus, our study focused on glioma cell lines derived from glioblastoma (WHO IV) and WHO II grade glioma. To ensure the high reproducibility and accuracy of the metabolomic signature, six or more independent replicates of each cell line were obtained under the same conditions. The careful selection of cell cultures with the same growth conditions could ensure no significant differences among the metabolic profiles caused by the extracellular environment among the metabolic profiles.
According to the literature[
20‐
22], we used the differentiation level and invasion ability to evaluate the malignant degrees of these cell lines after continuous subculture in vitro. The expression level of GFAP is an important index to assess the differentiation level of glioma cells[
23]. In addition, previous studies have shown that MMP-9 plays an important role in the invasion process of glioma cells[
24].The malignant transformation of glioma cells is accompanied by increased expression of MMP-9[
25]. The measured GFAP and MMP-9 expression levels showed that the high-grade cell lines (U87/U118/U251) possessed a lower level of differentiation and a higher invasion ability than the low-grade cell lines (CHG5/SHG44), indicative of the consistency between the malignant degree of cell lines and the pathology grades of their glioma tissues after continuous subculture in vitro.
By the unsupervised and supervised analyses of 1H NMR data for the five glioma cell lines, we found that the metabolic profiles of cell lines CHG5 and SHG44 (WHO II)were separated from those of U87,U118 and U251(WHO IV). The clustering of metabolic profiles was consistent with the cell lines grouping based on the pathology grades of their glioma tissues. These findings indicated a close correlation between the metabolic profiles of cell lines and their malignant behaviors. Seventeen characteristic metabolites were identified to distinguish the metabolic profiles of the cell lines. The metabolic profiles from cell lines might provide information associated with their malignant features and other biological features; therefore, we further investigated the correlation of these characteristic metabolites with the glioma malignant behavior markers GFAP and MMP-9. Nine characteristic metabolites were directly connected to the GFAP and MMP-9 pathway network, including Val, Glu, GSH, Tyr, Phe, Leu, Ace, GPC and Cr. The levels of metabolites Val, Glu, GSH, Tyr, Leu and GPC significantly increased, while those of other three metabolites Ace, Cr and Phe decreased in the high-grade group. It seems that the altered levels of these metabolites could be associated with the differentiation and invasion process of glioma cells.
Notably, most of these altered metabolites in the two groups were amino acids. The altered amino acids in the tumor are mostly involved in TCA cycle anaplerosis[
13] and protein biosynthesis[
26]. It has been reported that Phe, Tyr, Leu and Val are involved in anaplerosis, which enter the TCA cycle by being converted into fumarate and succinyl CoA, respectively[
27]. Moreover, glutamine is involved in anaplerosis through glutaminolysis, which enters the TCA cycle by being converted into glutamate initially and then into α-ketoglutarate[
28]. Even though, the level of Phe was decreased, the amino acids including Val, Gln, Tyr, Leu were generally up- regulated in the high group, suggesting that more active TCA cycle anaplerotic flux might occur during malignant transformation of glioma cells.
In addition to increased amino acids, a higher level of GPC in the high-grade group was observed. As one of important choline-containing metabolites, GPC is involved in choline phospholipid metabolism of cell membranes. Alterations in choline phospholipid metabolism, with consequent alterations of these choline-containing metabolites, are a common feature of the cancer[
29]. Thus, the increased level of GPC in the high-grade group might be related to the biosynthesis of cell membranes for rapid growth and high invasion ability. The metabolite GSH was also up-regulated in the high-grade group. As a ubiquitous intra- and extracellular protective antioxidant, GSH plays a key role in reducing reactive oxygen species and combating increased oxidative stress. A previous study reported that the level of reactive oxygen species in cancer cells was associated with malignant transformation[
30]. In addition, GSH is particularly vital in protecting cells from radiation damage, which has generated reactive oxygen species. Rosi
et al. found that a high level of GSH was correlated with radiation-induced apoptosis by MR spectra of cultured tumor cells[
31]. Thus, consistently with previous literature[
30,
31], the elevated GSH levels observed in our work might be related to enhanced antioxidant mechanisms in glioma cells with high malignant degree.
Decreased levels of creatine and acetate were observed in the high group. Both metabolites are usually detected in magnetic resonance imaging research of brain tumors. The creatine level reflect energy buffering and transport. Several studies have suggested that the creatine level in the low-grade gliomas is almost identical to that in the high-grade gliomas[
29,
32]. Nonetheless, some studies observed that decreased creatine levels in brain tumors and in rectal cancer tissues at different stages[
33,
34]. So far, the importance of creatine levels has remained unclear in the differentiation of low –grade from high-grade tumors[
35]. The down-regulation of creatine observed in our work might support its biological importance in glioma grading. Acetate can either be transformed into acetyl-CoA, entering the TCA cycle, or be used as a precursor of membrane fatty acids[
36], Nevertheless, the exact function of acetate in tumor cells remains unknown. Thus, the reason why acetate wa down-regulated in glioma cell lines in the high-grade group requires further investigations.
The other metabolites, including lactate, taurine, myo-inositol, lysine, isoleucine, threonine, formate, were not mapped into the GFAP/MMP-9 pathway network. However, some of them, such as lactate, taurine, myo-inositol, are metabolic markers frequently reported in cancers. Increased levels of lactate were detected in stomach cancer, oral cancer and rectal cancer tissues compared with the relevant normal tissues[
34]. Interestingly, the decreased level of lactate was observed in cells of head and neck squamous cell carcinoma, compared with those of normal human oral keratinocytes. We also found a decreased lactate level in glioma cell lines in the high-grade group. Lactate production, due to the high glycolytic rates in cancer cells, enhances intracellular acidosis, which in turn leads to apoptosis. Previous works[
37,
38] have also demonstrated that glioma cells could rapidly discharge lactate into the nearby microenvironment through monocarboxylate transporters. Thus, the lactate down-regulation observed in this work might be associated with the anti-apoptotic ability of glioma cells. Furthermore, taurine and myo-inositol are associated with osmo-regulation and volume regulation[
13]. In our study, the levels of taurine and myo-inositol in the two groups were significantly different, implying that these metabolites might be involved in osmoregulation and volume regulation of glioma cells.
To the best of our knowledge, this is the first study to explore the malignancy-associated metabolic signature of on glioma cell lines with different malignant degrees using NMR-based metabolomic analysis. Consistent with other studies[
14,
39], our results provide evidence that metabonomics analysis of cultured tumor cells is a valid method to understand the metabolic alterations accountable for their biological properties. Although we found that the characteristic metabolites are significantly associated with the malignant features of glioma cell lines, future works should be performed to further understand the regulation mechanism of the characteristic metabolites in malignant transformation.
Materials and methods
Cell lines, cell culture and cell proliferation assay
Five astrocytoma cell lines from glioma tissues with different pathological grades (CHG5, SHG44, U87, U118, U251, Table
1) were used in the present work. Cell lines (CHG5 and SHG44) were kindly provided by Professor XW Bian of the Third Military Medical University, China. Glioblastoma U87 and U118 cell lines were obtained from the American Type Culture Collection (ATCC). Glioblastoma U251 cell line was obtained by the China Center for Typical Culture Collection (CCTCC). All the cell lines were maintained in DMEM supplemented with 100 units/ml penicillin, 100 μg/ml streptomycin and 10% fetal bovine serum (FBS, Hyclone) at 37°C in a humidified atmosphere of 5% CO
2.
Five cell lines plated in 96-well plates (5 × 103 per well) were cultured for 24 h and 48 h. Cell samples were then incubated with CellTiter 96 AQueous solution (MTS, 20 μl/well) and culture medium (DMEM, 100 μl/well) for 4 h. Next, colored MTS products were detected by absorbance at 490 nm on a Molecular Devices Microplate Reader (BioTek, USA).
H&E and immunohistochemical stains
Cells were maintained on cover slips of 6-well plates in DMEM containing 10% fetal bovine serum as described above. At confluence, cells on cover slips were fixed with 4% paraformaldehyde for 15 min at room temperature, and were then stained with haematoxylin and eosin. Immunohistochemistry was performed as follows. Fixed cover slips were rinsed with 1% normal calf serum in PBS for 15 min, and permeabilized with 0.3% Triton X-100/PBS for 15 minutes. The cells were then incubated with primary antibodies specifically against GFAP(GA-5,MAIXIN-BiO) and MMP-9(56-1A4, MAIXIN-BiO) at 4°C overnight. The slides were washed with phosphate buffer solution (PBS) including 0.1% Triton X-100, incubated with biotinylated anti-mouse antibody (1:100) at 37°C for 1 hour, incubated with fluorescein isothiocyanate-labeled streptavidin conjugate (1:100) for 1 hour, and finally washed with PBS including 0.1% Triton X-100 three times, mounted, and analyzed under a microscope. The positive cells were counted and scored at a magnification of × 400 under a light microscope in five different fields for each coverslips. One-way analysis of variance (ANOVA) was used to determine the statistical significance of the differences among the five cell lines.
Invasion assay
The invasion assay was performed using transwell cell culture chambers (24 wells, 8-μm pore size; BD Biosciences). 1 × 105 tumor cells were resuspended in 200 μl of serum-free DMEM and added to the corresponding upper inserts, respectively. DMEM (600 μl) with 10% FBS was added to the lower chamber. After 24 h, invaded cells were fixed and stained with crystal violet (0.2% in 2% ethanol) for 20 min. Cells on the upper side of the insert membrane were removed with cotton rods. The invaded cells were counted at a magnification of × 100 under a light microscope in nine different fields for each insert. The measurements were repeated at least three times. One-way ANOVA was used to determine the statistical significance of the differences among five cell lines.
Before metabolite extraction, 1 × 10
6 cells were seeded in 10-cm diameter culture dishes and incubated for 48 h at 37°C and 5% CO
2. About 5 × 10
6 cells were then harvested and quenched by a direct cell quenching method, as described by Teng et al.[
40]. Intracellular metabolites were extracted using a dual phase extraction procedure adopted from Viant et al.[
41]. A mixture of methanol, chloroform and water in the volume ratio of 4:4:2.85 was used to generate a two-phase extract.
NMR analyses of intracellular extracts
In the present study, only the aqueous intracellular extracts were used. Before NMR analysis, solvents were completely removed using a Nitrogen Blowing Concentrator. Each aqueous sample was reconstituted in 500 μl of D
2O. Then 50 μl of D
2O containing 1.5 M KH
2PO
4 and 0.1% sodium 3-(trimethylsilyl)propionate-2,2,3,3-d4 (TSP) was added. D
2O was used for field frequency lock, and TSP was used to provide the chemical shift reference (d0.00). Subsequently, all the samples were vortexed, and centrifuged at 12000 g for 15 min at 4°C to remove any insoluble components. Finally the collected supernatants (500 μl) were transferred to 5 mm NMR tubes[
42].
All 1H NMR experiments were conducted on a Bruker Avance III 600 MHz spectrometer at 25°C. Solvent-suppressed 1D NOESY spectra were acquired using the pulse sequence [(RD)-90°-t1-90°-τm-90°-ACQ]. t1 was 6.6 μs. Water suppression was achieved by irradiation of the water resonance during the recycle delay ( RD ) of 4 s and the mixing time (τm) of 120 ms. The spectral width was 10 kHz with an acquisition time per scan of 1.64 s, and 256 transients were collected into 32 K data points for each spectrum. The free induction decay (FID) was zero-filled to 64 K and an exponential line-broadening function of 0.3 Hz was applied to the FID before Fourier transformation. Both phase and baseline corrections were carefully performed. The 1H NMR spectra were referenced to the methyl group of TSP (δ 0.00).
Multivariate statistical analysis
NMR spectra were reduced to 2587 integrated regions with a width of 0.003 ppm (bin) corresponding to the region of δ 9.5-0.8 using the MestRova6.5 software (Mestrelab Research S.L, Spain). The region of δ 5.5-4.5 was removed to eliminate artifacts related to the residual water resonance. (The remaining integrals for each NMR spectra were normalized to the sum of the spectral intensity to compensate for the differences in sample concentration)[
43].
Before multivariate statistical analysis, the integral values were mean-centered and pareto-scaled[
44]. To check general separation and identify the outliers, PCA was performed on NMR data sets of all cell samples using the SIMCA-P V12.0 software package (Umetrics AB, Umea, Sweden). Then, PLS-DA and OPLS-DA, were subsequently used to improve the separation[
45]. The PLS-DA model was cross-validated to measure the robustness by a permutation analysis with 999 times.
FCM is a clustering method that allows one piece of data to belong to two or more clusters and is extensively used in pattern recognition[
46,
47]. The FCM analysis was conducted by minimization of the following objective function:
Where m is any number greater than 1, uik is the degree of membership of xi in the cluster k, xi is the i-th measured data, vk is the center data of the k cluster. We used the FCM clustering algorithm through the Fuzzy Logic Toolbox in MATLAB (Version MATLAB2011b, MathWorks, USA).
Identification of characteristic metabolites and quantitative comparison
Two criteria were used to identify the characteristic metabolites. One was the VIP score of the OPLS-DA model[
48] and the other one was the correlation coefficient(r) of the variable relative to the predictive component(t[
1]) in the OPLS-DA model[
49]. The critical values of correlation coefficients were determined by the degrees of freedom in the OPLS-DA model. Characteristic metabolites with a VIP > 1 and |r| > the critical values were identified.
For relative quantification of characteristic metabolites, the relative integrals of metabolites were used for comparison between two groups. The average changes and standard error were calculated[
43].
Pearsons’s correlation coefficients of cell samples in two groups were further calculated to display the relationships between the relative integrals of spectral peaks in a certain biological profile, as described previously[
43]. A heatmap was used to display the correlation matrices. For all correlations, a p-value was calculated based on a t-test to check the statistical significance. The significance threshold was set to the usual value of 0.05 and corrected according to the number of potential correlations[
50].
The network of the metabolites with significance correlations was displayed by MATLAB Bioinformatics toolbox. Significant positive correlations were shown in red, while significant negative correlations were in blue. In addition, GeneGo MetaCore was used to analyze the network that describes the interaction between the characteristic metabolites and GFAP/MMP-9[
19].
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Experimental design and manuscript writing: WS, CHH, DHL. Financial support: DHL, THJ. Collection of samples and interpretation of results: DL, ZCH, ZL, WSY, KL. Collection and analysis of 1H NMR data: JPG, HYH. All authors read and approved the final manuscript.